首页 | 本学科首页   官方微博 | 高级检索  
     

异体NK细胞过继免疫在治疗血液肿瘤中的机制及应用
引用本文:冯秀,苏丽萍. 异体NK细胞过继免疫在治疗血液肿瘤中的机制及应用[J]. 国际肿瘤学杂志, 2012, 39(4): 304-307
作者姓名:冯秀  苏丽萍
作者单位:030013 太原,山西医科大学附属山西省肿瘤医院血液科
摘    要: 自然杀伤(NK)细胞是人体天然免疫系统的主要组成部分,其对血液肿瘤细胞的杀伤主要是由其表面抑制性受体和活化性受体所传递的信号共同决定。近年来,异体半相合NK细胞在造血干细胞移植和过继性细胞免疫治疗方面均显示出对人类血液系统肿瘤的积极治疗作用,为以NK细胞为基础的过继免疫治疗的临床应用提供了可能。

关 键 词:杀伤细胞  天然  血液肿瘤  免疫疗法  

Mechanism and application of NK cell-based adoptive immunotherapy in hematologic tumor
FENG Xiu,SU Li-Ping. Mechanism and application of NK cell-based adoptive immunotherapy in hematologic tumor[J]. Journal of International Oncology, 2012, 39(4): 304-307
Authors:FENG Xiu  SU Li-Ping
Affiliation:Department of Hematology, Affiliated Shanxi Tumor Hospital, Shanxi Medical University, Taiyuan 030013, China
Abstract:Natural killer (NK) cells are key members of the innate immune system. The capability of NK cells to kill hematological tumor cells mainly depends on the synthesis of stimulatory and inhibitory signals on the cells surface. In recent years, allogeneic haplo-identical NK cells have shown positive effect of hematologic tumor in hematologic stem cell transplantation and adoptive immunotherapy, and the natural killer cell-based immunotherapy would be applied in clinical.
Keywords:Kill cells, natural  Hematologic neoplasms  Immunotherapy
点击此处可从《国际肿瘤学杂志》浏览原始摘要信息
点击此处可从《国际肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号